Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study

  1. Ahn, M.J.
  2. Kim, H.R.
  3. Yang, J.C.H.
  4. Han, J.-Y.
  5. Li, J.Y.-C.
  6. Hochmair, M.J.
  7. Chang, G.-C.
  8. Delmonte, A.
  9. Lee, K.H.
  10. Campelo, R.G.
  11. Gridelli, C.
  12. Spira, A.I.
  13. Califano, R.
  14. Griesinger, F.
  15. Ghosh, S.
  16. Felip, E.
  17. Kim, D.-W.
  18. Liu, Y.
  19. Zhang, P.
  20. Popat, S.
  21. Camidge, D.R.
Revista:
Clinical Lung Cancer

ISSN: 1938-0690,  1525-7304

Ano de publicación: 2022

Volume: 23

Número: 8

Páxinas: 720-730

Tipo: Artigo

DOI: 10.1016/J.CLLC.2022.07.008 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus